Uzma Berhad (KLSE:UZMA)

Lumos Pharma Balance Sheet

Financials in millions MYR. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	46.47	71.16	44.49	56	84.65	103.62
Short-Term Investments	-	8.49	6.62	33.42	37.05	13.34
Trading Asset Securities	-	0.02	0.26	0.24	1.37	1.4
Cash & Short-Term Investments	46.47	79.68	51.37	89.65	123.07	118.35
Cash Growth	-55.65%	55.12%	-42.71%	-27.15%	3.99%	107.41%
Accounts Receivable	316.16	165.11	286.76	264.2	228.18	216.68
Other Receivables	6.24	34.84	33.84	48.87	21.27	80.6
Receivables	322.41	199.95	320.6	313.08	249.45	297.28
Inventory	67.39	74.65	52.29	50.89	40.5	46.2
Prepaid Expenses	-	7.39	5.68	5.79	6.26	8.97
Other Current Assets	51.39	111.22	63.36	51.2	47.44	73.55
Total Current Assets	487.65	472.89	493.29	510.61	466.71	544.34
Property, Plant & Equipment	1,067	818.35	566.4	520.61	537.23	530.1
Long-Term Investments	7.12	7.17	12.93	15.57	16.4	16.33
Goodwill	-	186.92	186.08	181.9	177.77	179.87
Other Intangible Assets	196.72	16.62	20.01	23	25.69	34.01
Long-Term Deferred Tax Assets	8.2	8.06	2.4	2.37	5.69	6.28
Other Long-Term Assets	14.42	10.37	5.98	5.96	6.75	6.48
Total Assets	1,781	1,520	1,287	1,260	1,236	1,317
Accounts Payable	157.64	88.13	120.84	129.74	116.48	98.04
Accrued Expenses	-	9.1	8.73	60.7	38.47	77.29
Short-Term Debt	206.38	179.94	129.6	126.08	105.04	99.63
Current Portion of Long-Term Debt	96.43	87.69	94.07	93.68	104.42	103.13
Current Portion of Leases	4.03	3.66	5.98	3.65	5.99	6.87
Current Income Taxes Payable	-	4.26	0.16	0.58	0.55	0.75
Current Unearned Revenue	69.24	26.25	50.83	0.36	0.39	1
Other Current Liabilities	-	58.13	98	28.14	21.46	18.37
Total Current Liabilities	533.72	457.17	508.21	442.91	392.8	405.07
Long-Term Debt	542.43	350.42	138.89	234.12	305.18	380.18
Long-Term Leases	12.43	13.51	12.58	12.95	6.81	9.92
Long-Term Unearned Revenue	10.7	11.95	13.61	14.86	6	7.47
Long-Term Deferred Tax Liabilities	32.77	26.75	24.45	23.65	17.94	17.99
Other Long-Term Liabilities	-	12.85	23.54	4.15	3.91	3.78
Total Liabilities	1,135	875.52	723.91	735.38	735.53	827.33
Common Stock	388.03	383.52	307.54	307.54	290.07	290.07
Retained Earnings	230.6	217.3	180.03	146.43	143.35	151.64
Comprehensive Income & Other	8.22	11.43	45.24	41.08	36.35	15.37
Total Common Equity	626.85	612.25	532.81	495.04	469.76	457.07
Minority Interest	19.12	32.61	30.37	29.58	30.95	33.01
Shareholders' Equity	645.97	644.86	563.19	524.62	500.71	490.09
Total Liabilities & Equity	1,781	1,520	1,287	1,260	1,236	1,317
Total Debt	861.71	635.22	381.12	470.47	527.44	599.73
Net Cash (Debt)	-815.24	-555.55	-329.75	-380.82	-404.37	-481.37
Net Cash Per Share	-1.76	-1.08	-0.70	-0.84	-0.95	-1.13
Filing Date Shares Outstanding	588.4	580.44	516.31	469.37	426.7	426.7
Total Common Shares Outstanding	588.4	580.44	469.37	469.37	426.71	426.71
Working Capital	-46.07	15.71	-14.92	67.7	73.91	139.28
Book Value Per Share	1.07	1.05	1.05	0.97	1.01	1.07
Tangible Book Value	430.13	408.71	326.71	290.14	266.31	243.2
Tangible Book Value Per Share	0.73	0.70	0.61	0.53	0.53	0.57
Machinery	-	775.81	722.88	686.77	676.26	628.24
Construction In Progress	-	317.54	75.17	20.39	21.07	17.44
Leasehold Improvements	-	0.77	0.7	0.65	0.67	0.72
Order Backlog	-	2,950	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.